Solid Biosciences Inc (SLDB)
10.35
+0.10
(+0.98%)
USD |
NASDAQ |
May 03, 14:48
Solid Biosciences Accounts Receivable (Quarterly)
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.014M |
| December 31, 2021 | 0.11M |
| Date | Value |
|---|---|
| September 30, 2021 | 0.594M |
| June 30, 2021 | 0.286M |
| March 31, 2021 | 0.28M |
| December 31, 2020 | 0.00 |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
Dec 2020
0.594M
Maximum
Sep 2021
0.1605M
Average
0.062M
Median
Accounts Receivable (Quarterly) Benchmarks
| Sarepta Therapeutics Inc | 378.81M |
| PTC Therapeutics Inc | 197.66M |
| Capricor Therapeutics Inc | 10.37M |
| Perspective Therapeutics Inc | 1.165M |
| Electromed Inc | 22.99M |